Incyte Corporation (INCY)

Trade INCY now with
4/30/2019 7:07:06 AM Incyte Q1 EPS $0.47; Non-GAAP EPS $0.62
2/14/2019 7:03:28 AM Incyte Q4 EPS $0.32 Vs Loss $0.71 Last Year
2/7/2019 7:06:28 AM Incyte Says FDA Extended Review Period For Ruxolitinib In Acute Graft-Versus-Host Disease
2/4/2019 6:46:28 AM Lilly Says Baricitinib Meet Primary Endpoint In BREEZE-AD1 And BREEZE-AD2 Phase 3 Studies
1/22/2019 7:30:21 AM Incyte Announces First Patient Treated In Phase 3 Clinical Trial Of Itacitinib For Chronic Graft-Versus-Host Disease
1/7/2019 7:03:34 AM Merus Says FDA Accepted IND Application For MCLA-145
1/3/2019 7:00:49 AM Incyte Appoints Christiana Stamoulis As CFO, Effective Feb 11
12/13/2018 6:53:35 AM Lilly:FDA Grants Fast Track Designation To Baricitinib Development Program For Treatment Of Systemic Lupus Erythematosus
12/3/2018 10:07:17 AM Incyte Announces Updated Results From Its Pivotal Phase 2 REACH1 Study
11/27/2018 7:30:38 AM Incyte Appoints Dashyant Dhanak As Chief Scientific Officer